SEC Form 4 · accession 0001652252-18-000011
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giovanni Magni
Officer — EVP, Chief Strategy Officer
Period of report
Sep 4, 2018
Accepted (ET)
Sep 6, 2018 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | holding | — | — | — | 10,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Sep 4, 2018 | A | 2,500 | A | — | — | Bio-Rad A Common Stock | 2,500 | 2,500 | D |
| Non-Qualified Stock Option (right to buy)F3 | $326.15 | Sep 4, 2018 | A | 2,500 | A | — | Sep 4, 2028 | Bio-Rad A Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F2The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
- F3The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.